China's JD Health and Ali Health have long-term upside ahead, analyst says

Online penetration for medicinal prescription sales has been less than 2% in China over the last year, but it still has more room to grow, says Shuang Geng of Blue Lotus Capital Advisors.
Mon, Dec 21 20202:18 AM EST